How to find the best pharmaceutical stocks for your health
Top pharmaceutical stocks are the top stock choices for investors seeking high returns.
They include generic medicines and specialty medicines.
Here are the best drugs and stocks for medical professionals.
Merck & Co. MEDKA, +0.01% Merck Inc., the world’s largest maker of antibiotics, is a pharmaceutical company based in Indianapolis, Indiana.
The company has been in business for over a century and is a global leader in developing and manufacturing medicines for the treatment of infections, including pneumonia, influenza, tuberculosis, and other infectious diseases.
Merk’s stock surged in the wake of the 2016 pandemic.
The stock closed Friday at $55.96, a 27% gain over the previous session.
The latest Nasdaq composite index tracking company said in a report that Merck’s share price has climbed from $37.85 in February to $54.85 today.
This was the second-highest gain among the S&P 500 companies in February.
The market’s highest gain for the year was 6.5%, according to FactSet data.
Pfizer Inc. PFE, +1.17% Pfizer, Inc., is a biotechnology company based near Cincinnati, Ohio.
Pfiz is a specialty pharmaceutical company that specializes in the treatment and prevention of diseases such as diabetes, obesity, and heart disease.
Pfi’s stock has been rising recently.
The Dow Jones Industrial Average is up 5% since April 1, with the S.&.
P. index up 9%.
Pfiz’s stock is up about 7% over the past year.
Valeant Pharmaceuticals NV, +2.19% Valeant is a healthcare company with operations in more than 40 countries.
Valeants is a leader in the development and manufacturing of life-saving medications for cancer patients and those suffering from cardiovascular disease.
The stocks surged in 2016, with a record $25.3 billion in revenue and $4.6 billion in sales.
The Nasdaq Composite is up 12% over 2016 and the S-Shares index is up 6%.
Merrimack Health Sciences Inc. MERRY, +3.33% Merrimaches Health Sciences is a company that develops, manufactures and markets medicines for chronic diseases.
The drugmaker also develops and manufactures medicines for pediatric and elderly patients, including asthma and diabetes.
Its stock is on track to grow by over 1,000% over this year.
The S&s index is also up 7%.
Johnson &amass, +4.19